Targeting regulatory T cells in tumor immunotherapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Targeting regulatory T cells in tumor immunotherapy

Published:2014-04-29 Issue:6 Volume:92 Page:473-474
ISSN:0818-9641
Container-title:Immunology & Cell Biology
language:en
Short-container-title:Immunol Cell Biol

Author:

Smyth Mark J¹²,Ngiow Shin Foong³,Teng Michele WL²³

Affiliation:

1. Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research InstituteHerstonQueenslandAustralia

2. School of Medicine, University of QueenslandSt LuciaQueenslandAustralia

3. Cancer Immunoregulation and Immunotherapy Laboratory, QIMR Berghofer Medical Research InstituteHerstonQueenslandAustralia

Funder

Prostate Cancer Foundation of Australia

Publisher

Wiley

Subject

Cell Biology,Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1038/icb.2014.33

Reference12 articles.

1. Translating basic mechanisms of IgG effector activity into next generation cancer therapies;Nimmerjahn F;Cancer Immun,2012

2. OX40 engagement depletes intratumoral Tregs via activating FcγRs, leading to antitumor efficacy

3. Breathing new life into immunotherapy: review of melanoma, lung and kidney cancer

4. Conditional Regulatory T-Cell Depletion Releases Adaptive Immunity Preventing Carcinogenesis and Suppressing Established Tumor Growth

5. Multiple Antitumor Mechanisms Downstream of Prophylactic Regulatory T-Cell Depletion

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CD25 : A potential tumor therapeutic target;International Journal of Cancer;2022-10

2. Targeting TNFR2: A Novel Breakthrough in the Treatment of Cancer;Frontiers in Oncology;2022-04-14

3. Two novel human anti-CD25 antibodies with antitumor activity inversely related to their affinity and in vitro activity;Scientific Reports;2021-11-25

4. Carcinoma epidermoide cutáneo avanzado tratado con pembrolizumab;Actas Dermo-Sifiliográficas;2021-07

5. Advanced Cutaneous Squamous Cell Carcinoma Treated with Pembrolizumab;Actas Dermo-Sifiliográficas (English Edition);2021-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3